Health

Tags:

“The EU is fully engaged in the fight against Ebola”

This is a global crisis which concerns all of us. It is a tragic reminder that we must never let down our guard. We pay the price of complacency with human suffering and loss of life.

Tags:

Behavioral Therapy Deemed Best for Social Phobia

But finding a specialist isn't easy, experts say.

psychiatrist.jpg

Tags:

Nature Walks With Others May Keep Depression at Bay

Study found they lowered stress levels, lifted spirits after illness, job loss, divorce, death of loved one.

couple_18284_0.jpg

Tags:

Ebola Requires the World’s United Action

frieden_in_ppe-300x199.jpg
Dr. Tom Frieden, Director of the U.S. Centers for Disease Control and Prevention, prepares to don goggles before entering the Ebola treatment unit (ETU), ELWA 3.

Tags:

UN chief to leaders: ‘The world can and must stop Ebola – now’

09-25-2014WHO_Ebola_0.jpg

Tags:

WHO: Ebola Most Challenging Epidemic ‘in Decades’

FFFA213A-3D80-490E-B72B-149B7B5E0E09_w640_r1_s_0.jpg
Ebola virus, rapid rise in epidemic, Sept. 25, 2014

Tags:

World Bank Group to Nearly Double Funding in Ebola Crisis to $400 Million

Significant new assistance planned for hardest-hit countries

Following alarming evidence of the spread of the Ebola epidemic in West Africa, the World Bank Group announced that it will nearly double its financing to $400 million to help the worst-affected countries address the emergency and build stronger health systems for the years ahead

Tags:

NIH and VA address pain and related conditions in U.S. military personnel, veterans, and their families

Research will focus on nondrug approaches

Thirteen research projects totaling approximately $21.7 million over 5 years will explore nondrug approaches to managing pain and related health conditions such as post-traumatic stress disorder (PTSD), drug abuse, and sleep issues. The effort seeks to enhance options for the management of pain and associated problems in U.S. military personnel, veterans, and their families.

Tags:

NIH and FDA win top award for intellectual property licensing of meningitis vaccine

NIH and the FDA teamed with PATH External Web Site Policy, a Seattle-based non-profit leader in global health innovation, and the Serum Institute of India (SII) to develop MenAfriVac. The vaccine has a low production cost and does not require constant refrigeration, making it ideal for use in remote locations.

Tags:

NIH exceptional responders to cancer therapy study launched

The Exceptional Responders Initiative, a study to investigate the molecular factors of tumors associated with exceptional treatment responses of cancer patients to drug therapies, was launched by the National Cancer Institute (NCI), part of the National Institutes of Health.